The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults. Although aerosolized ribavirin was licensed for RSV treatment on the basis of data demonstrating a reduced need for supplemental oxygen, ribavirin use...

Descripción completa

Detalles Bibliográficos
Autores principales: Domachowske, Joseph B., Anderson, Evan J., Goldstein, Mitchell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926075/
https://www.ncbi.nlm.nih.gov/pubmed/33656652
http://dx.doi.org/10.1007/s40121-020-00383-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926075/
https://www.ncbi.nlm.nih.gov/pubmed/33656652
http://dx.doi.org/10.1007/s40121-020-00383-6

Ejemplares similares